Sequella Archives · BioBuzz

Loading …

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

<img width="270" height="284" alt="Carol Nacy, Ph.D." data-src="https://biobuzz.io/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3-270x284.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="270" height="284" src="https://biobuzz.io/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3-270x284.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="Carol Nacy, Ph.D." />

Published on : August 27, 2018October 10, 2018 Published by : Steven Surdez

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all [….]